Fig. 5
Different therapeutic effects of CL-, CPJ- and FP-MSCs on the treatment of ALF mice. a Survival rates of the CCl4-induced ALF mouse model treated by different types of MSCs (n = 15 for control group and n = 45 for other groups). b Serum ALT and AST levels (n = 6 for each group). c H&E staining of liver sections from different treatment groups (400 ×). CV (Central vein), PV (portal vein) and B (bile ducts). d SOD, GSH-px, MDA, IL6 in liver homogenate detected by ELISA (n = 6 for each group). * represents a significant difference (p < 0.05). ** represents a significant difference (p < 0.01). *** represents a significant difference (p < 0.001). Different superscripts within a column indicate a significant difference (p < 0.05)